Semaglutide minimizes blood glucose through a system where it stimulates insulin secretion and lowers glucagon secretion, both equally in a glucose-dependent way. Specific Populations According to a populace pharmacokinetic analysis, age, sexual intercourse, race, and ethnicity, and renal impairm